About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CytoMed Therapeutics Limited - Ordinary Shares (NQ:GDTC)

1.010 -0.010 (-0.98%)

Streaming Delayed Price Updated: 10:30 AM EST, Feb 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CytoMed Therapeutics Limited - Ordinary Shares

< Previous 1 2 3 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 19, 2024

Pre-market stock movers are a hot topic on Friday as we check out all of the stories affecting shares on the last day of trading this week!

Via InvestorPlace

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

July 17, 2024

Another Patent Granted for CytoMed's Allogeneic Induced Pluripotent Stem Cell (“iPSC”)-derived Hybrid Gamma Delta Natural Killer T (γδ NKT) cells technology

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

Navigating the Challenges Facing an Aging Global Population: How CytoMed Seeks to Help Boost Cartilage Regeneration

March 20, 2024

The global population is rapidly aging. According to the World Population Prospects 2022 published by the United Nations, there were

Via Spotlight Growth

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

March 20, 2024

Via ACCESSWIRE

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

March 18, 2024

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

March 04, 2024

CytoMed diversifies into regenerative medicine

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 07, 2024

Via Benzinga

US Stocks Gain; Uber Posts Upbeat Sales ↗

February 07, 2024

U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.25% to 38,618.79 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Why Container Store Group Shares Are Trading Lower By Around 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 07, 2024

Shares of The Container Store Group, Inc. (NYSE: TCS) shares fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 07, 2024

Via Benzinga

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

January 29, 2024

The Company now has exclusive rights to a Malaysia, US and China patent

From CYTOMED THERAPEUTICS LIMITED

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 27, 2023

Via Benzinga

Singapore’s Journey to Becoming a Biotech Powerhouse

October 24, 2023

Singapore's Biotech Vision: From 2000 Onwards In 2000, Singapore embarked on an ambitious mission to establish itself as a leading

Via Spotlight Growth

Topics Economy

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 09, 2023

Via Benzinga

CytoMed Expands Research Collaboration into China After Entering Into MOU

August 29, 2023

Via ACCESSWIRE

Singapore’s Leap into the Future of Cell and Gene Therapies

August 29, 2023

Singapore is making remarkable progress in the realm of cell and gene therapy (CGT), as evidenced by the inauguration of

Via Spotlight Growth

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal ↗

August 19, 2023

Jiangsu Hengrui Pharma out-licensed global rights (ex-China) for a novel anti-inflammatory to One Bio of Florida in a $1 billion deal. One Bio will make an $21.5 million payment upfront along with a...

Via Talk Markets

The Dawn of a New Era in Immunotherapy for Cancers: Understanding CytoMed Therapeutics’ (NASDAQ: GDTC) iPSC-Derived Gamma Delta NKT Cell Technology

July 27, 2023

CytoMed Therapeutics, a NASDAQ-listed company (Stock Symbol: GDTC), is at the forefront of a revolution in cellular therapy for cancers.

Via Spotlight Growth

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 ↗

July 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 13, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 12, 2023

Via Benzinga

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 12, 2023

Via Benzinga

Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 12, 2023

Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 12, 2023

It's time to start off Wednesday with an overview of all the biggest pre-market stock movers worth watching this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 11, 2023

Via Benzinga

Why Siyata Mobile Shares Are Trading Lower By 21%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

July 11, 2023

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

CytoMed Therapeutics Limited - Ordinary Shares (NQ:GDTC)

All News about CytoMed Therapeutics Limited - Ordinary Shares

Sections

Services

Contact Information

Follow Us